Eutilex.Co.Ltd (263050) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.083x

Based on the latest financial reports, Eutilex.Co.Ltd (263050) has a cash flow conversion efficiency ratio of -0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.41 Billion ≈ $-1.63 Million USD) by net assets (₩28.91 Billion ≈ $19.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 263050 net asset quality score to measure how much of total assets are equity-financed.

Eutilex.Co.Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Eutilex.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore 263050 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Eutilex.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eutilex.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Conduril - Engenharia S.A LS:CDU	N/A
Rex Industry Bhd KLSE:9946	-0.129x
Rossell India Limited NSE:ROSSELLIND	-0.043x
Yayla Enerji Uretim Turizm ve IS:YAYLA	-0.003x
Western Exploration Inc V:WEX	-0.049x
Lumens Co. Ltd KQ:038060	0.074x
Atech OEM TWO:6109	-0.036x
Pion Group AB Series B ST:PION-B	-0.103x

Annual Cash Flow Conversion Efficiency for Eutilex.Co.Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Eutilex.Co.Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 263050 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩39.94 Billion ≈ $27.07 Million	₩-21.40 Billion ≈ $-14.50 Million	-0.536x	-26.63%
2023-12-31	₩60.44 Billion ≈ $40.96 Million	₩-25.58 Billion ≈ $-17.33 Million	-0.423x	-24.17%
2022-12-31	₩87.75 Billion ≈ $59.47 Million	₩-29.90 Billion ≈ $-20.26 Million	-0.341x	+13.88%
2021-12-31	₩68.38 Billion ≈ $46.34 Million	₩-27.06 Billion ≈ $-18.34 Million	-0.396x	-30.05%
2020-12-31	₩58.51 Billion ≈ $39.65 Million	₩-17.80 Billion ≈ $-12.07 Million	-0.304x	-42.14%
2019-12-31	₩62.83 Billion ≈ $42.58 Million	₩-13.45 Billion ≈ $-9.11 Million	-0.214x	-62.31%
2018-12-31	₩77.49 Billion ≈ $52.52 Million	₩-10.22 Billion ≈ $-6.93 Million	-0.132x	-24.07%
2017-12-31	₩51.13 Billion ≈ $34.65 Million	₩-5.44 Billion ≈ $-3.68 Million	-0.106x	+25.20%
2016-12-31	₩25.87 Billion ≈ $17.53 Million	₩-3.68 Billion ≈ $-2.49 Million	-0.142x	--

About Eutilex.Co.Ltd

KQ:263050 Korea Biotechnology

Market Cap

$23.94 Million

₩35.32 Billion KRW

Market Cap Rank

#24475 Global

#1728 in Korea

Share Price

₩959.00

Change (1 day)

+29.95%

52-Week Range

₩683.00 - ₩1812.00

All Time High

₩41553.86